Skip to content

Comparison of the effect of remimazolam versus propofol on regional cerebral oxygenation and hemodynamics during orthopedic surgery in the sitting position

Comparison of the effect of remimazolam versus propofol on regional cerebral oxygenation and hemodynamics during orthopedic surgery in the sitting position

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007400
Enrollment
104
Registered
2022-06-16
Start date
2022-06-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients were randomly divided into two groups using a random number table (Excel computer program, Microsoft, Redmont, WA). A The anesthesiologist confirms the experimental group, injects the

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients with scheduled surgery requiring general anesthesia - Patients scheduled for orthopedic surgery in a sitting position - Class I, II, III of the American Society of Anesthesiologist (ASA) physical status classification system designated by the American Association of Anesthesiologists - Age 19 -75 years

Exclusion criteria

Exclusion criteria: - Hemodynamically unstable patients - Patients with serious cerebrovascular disease or heart disease - Patients with cognitive impairment - 18 years old or younger, over 76 years old - ASA status IV or V

Design outcomes

Primary

MeasureTime frame
regional tissue oxygen saturation

Secondary

MeasureTime frame
mean arterial pressure, heart rate, oxygen saturation, complication such as cerebral infarction, cognitive disorder

Countries

Korea, Republic of

Contacts

Public ContactJeongMin Sung

Hanyang University Seoul Hospital

dark5234@naver.com+82-2-2290-8680

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026